islam-laparoscopicmetabolic-2018.pdf (1.01 MB)
Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis
journal contribution
posted on 2018-09-17, 00:00 authored by Zhiyong Dong, Shariful IslamShariful Islam, Ashley M Yu, Rui Qu, Bingsheng Guan, Junchang Zhang, Zhao Hong, Cunchuang WangBACKGROUND: Laparoscopic metabolic surgery has been previously shown to be an effective treatment for obese patients with type 2 diabetes (T2DM). The objective of this scoping review is to determine the impact of metabolic surgery for the treatment of type 2 diabetes in Asia and perform an evidence-based analysis. METHODS: We performed a literature search in PubMed for research on laparoscopic metabolic surgery for the treatment of T2DM in Asia region. We classified the included studies based on the Oxford Center for Evidence Based Medicine guidelines. And performed and evidence analysis. RESULTS: In total, 205 articles were identified. 62.9% of the studies were from East Asia. The evidence of 26 studies are level I, 59 are level II. Laparoscopic sleeve gastrectomy (LSG) was the most commonly reported surgical procedure (63.1%) in Asia. The number of laparoscopic metabolic surgery for T2DM in Asian countries has increased rapidly over the last 8 years. We identified 16 studies which showed that laparoscopic metabolic surgery is an effective and safe treatment for T2DM in patients with a BMI of > 25 kg/m2 to < 35 kg/m2 in Asia. CONCLUSIONS: Our results suggest that laparoscopic metabolic surgery might be an effective and safe treatment for T2DM patients with BMI < 35 kg/m2, and that LSG is the most commonly performed surgical procedure for this in Asia.
History
Journal
BMC surgeryVolume
18Issue
1Article number
73Publisher
BioMed CentralLocation
London, Eng.Publisher DOI
Link to full text
ISSN
1471-2482eISSN
1471-2482Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, The AuthorsUsage metrics
Categories
No categories selectedKeywords
BMI < 35 kg\/m2, evidence-based analysisMetabolic surgeryObesityType 2 diabetesScience & TechnologyLife Sciences & BiomedicineSurgeryBMI < 35 kg\/m(2)evidence-based analysisROUX-EN-YBODY-MASS INDEXCLINICAL-PRACTICE GUIDELINESMINI-GASTRIC BYPASSSHORT-TERM OUTCOMESSLEEVE GASTRECTOMYBARIATRIC SURGERYMORBID-OBESITYAMERICAN ASSOCIATIONCHINESE PATIENTS
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC